Abstract| Volume 263, e218, August 2017

Antioxidant property of HDL as well as cholesterol efflux capacity are independent risk markers for atherosclerotic cardiovascular disease in patients with familial hypercholesterolemia

      Aim: Interventions or genetic variants that raise HDL cholesterol do not reduce risk of atherosclerotic cardiovascular disease (ASCVD). Therefore, studies of HDL functionalities rather than HDL cholesterol levels are encouraged. We previously reported that cholesterol efflux capacity was independently and inversely associated with the presence of ASCVD in 227 familial hypercholesterolemia (FH) patients. Accordingly, we aimed to investigate the association between antioxidant property of HDL, another functionality, and the presence of ASCVD in 332 statin-treated heterozygous FH patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect